Open access
Aug 2026
Shenling Baizhu powder alleviates non-alcoholic steatohepatitis by reducing PPARα-mediated NLRP3 inflammasome activation
Introduction Nonalcoholic steatohepatitis (NASH) is the progressive stage of nonalcoholic fatty liver disease characterized by varying degrees of inflammation, hepatic steatosis, liver cell damage and fibrosis, which can seriously harm people’s health. Shenling Baizhu (SL) powder exhibits a strong capacity to modulate...
Si-Yuan Huang, Yuan-Jun Deng, Da-Jin Pi et al.
· Frontiers in Immunology · 0 citations